UCB, Inc.

UCB, Inc. – Product Catalog (A–Z)

Bimzelx → Generic: bimekizumab (IL-17A & IL-17F inhibitor) → Indication: Moderate–severe plaque psoriasis, psoriatic arthritis, axial spondyloarthritis → Dose: SC injection 320 mg q4w (maintenance q8w)

Briviact → Generic: brivaracetam → Indication: Epilepsy (partial-onset seizures, adjunct or monotherapy) → Dose: Tablets 25–100 mg; oral solution; IV injection

Cimzia → Generic: certolizumab pegol (anti-TNF biologic) → Indication: Crohn’s disease, RA, axial spondyloarthritis, psoriatic arthritis, plaque psoriasis → Dose: Prefilled syringe/pen 200 mg SC q2–4w

Keppra / Keppra XR → Generic: levetiracetam → Indication: Epilepsy (partial, myoclonic, tonic-clonic seizures) → Dose: Tabs 250–1000 mg; XR 500–750 mg; oral solution; IV infusion

Nayzilam → Generic: midazolam nasal spray → Indication: Acute repetitive seizures (rescue therapy) → Dose: Nasal spray 5 mg/spray

Neupro → Generic: rotigotine (transdermal patch) → Indication: Parkinson’s disease, restless legs syndrome (RLS) → Dose: Patches 1–8 mg/24 hr

Rystiggo → Generic: rozanolixizumab-noli (anti-FcRn antibody) → Indication: Generalized myasthenia gravis (gMG, AChR+ or MuSK+) → Dose: SC infusion 7–10 mg/kg once weekly × 6 weeks

Vimpat → Generic: lacosamide → Indication: Epilepsy (partial-onset, primary generalized tonic-clonic seizures) → Dose: Tabs 50–200 mg; oral solution; IV infusion

Zilbrysq → Generic: zilucoplan (C5 complement inhibitor, SC peptide) → Indication: Generalized myasthenia gravis (AChR+) → Dose: SC injection 0.3 mg/kg daily